These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6176492)

  • 1. Metabolism of 5-fluorouracil in various human normal and tumor tissues.
    Maehara Y; Nagayama S; Okazaki H; Nakamura H; Shirasaka T; Fujii S
    Gan; 1981 Dec; 72(6):824-7. PubMed ID: 6176492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of uracil on metabolism of 5-fluorouracil in vitro.
    Ikenaka K; Shirasaka T; Kitano S; Fujii S
    Gan; 1979 Jun; 70(3):353-9. PubMed ID: 467897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of catabolic pathway of 5-fluorouracil by 3-cyano-2,6-dihydroxypyridine in human lung cancer tissues.
    Okayasu T; Sugiyama K; Miyauchi S
    Jpn J Cancer Res; 1994 Jan; 85(1):101-5. PubMed ID: 8106287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pyrimidine nucleotide synthetic enzymes involved in 5-fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas.
    Maehara Y; Moriguchi S; Emi Y; Watanabe A; Kohnoe S; Tsujitani S; Sugimachi K
    Cancer; 1990 Jul; 66(1):156-61. PubMed ID: 2162241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa.
    Peters GJ; van Groeningen CJ; Laurensse EJ; Pinedo HM
    Cancer; 1991 Nov; 68(9):1903-9. PubMed ID: 1717130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.
    Shirasaka T; Shimamoto Y; Fukushima M
    Cancer Res; 1993 Sep; 53(17):4004-9. PubMed ID: 7689420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on the permeability of FT-207 and 5-FU in primary lung cancer].
    Aogauchi R; Tsubota N; Yamashita C; Yoshikawa K; Ishii N; Nakamura K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):105-10. PubMed ID: 3917651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma.
    Houghton JA; Houghton PJ
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):807-15. PubMed ID: 6191988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil is converted to F-nucleotides more extensively and is more cytotoxic in poorly differentiated than in well differentiated human gastric carcinoma.
    Maehara Y; Kusumoto T; Emi Y; Anai H; Sakaguchi Y; Kohnoe S; Sugimachi K
    Anticancer Res; 1990; 10(4):1091-4. PubMed ID: 2382981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
    Oiwa T; Saito H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estimation of pathways of 5-fluorouracil anabolism in human cancer cells in vitro and in vivo].
    Fukushima M; Nomura H; Murakami Y; Shirasaka T; Aiba K
    Gan To Kagaku Ryoho; 1996 May; 23(6):721-31. PubMed ID: 8645024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and distribution studies with radiolabeled 5-fluorouracil.
    Young D; Vine E; Ghanbarpour A; Shani J; Siemsen JK; Wolf W
    Nuklearmedizin; 1982 Feb; 21(1):1-7. PubMed ID: 6281741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects].
    Kato H; Inoue S; Takahashi K; Yamanaka A; Okada Y
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1866-70. PubMed ID: 3036016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon and the incorporation of 5-fluorouracil into RNA of normal tissues and a secondary liver carcinoma in rat.
    Roos G; Stenram U
    Anticancer Res; 1994; 14(2A):379-82. PubMed ID: 7517119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoribosyl pyrophosphate, pool size and tissue levels as a determinant of 5-fluorouracil response in murine colonic adenocarcinomas.
    Ardalan B; Villacorte D; Heck D; Corbett T
    Biochem Pharmacol; 1982 Jun; 31(11):1989-92. PubMed ID: 6180752
    [No Abstract]   [Full Text] [Related]  

  • 16. Biliary glycoprotein mRNA expression is increased in primary lung cancer, especially in squamous cell carcinoma.
    Ohwada A; Takahashi H; Nagaoka I; Kira S
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):214-20. PubMed ID: 8049082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
    Suzuki M; Sekiguchi I; Ohwada M; Tamada T
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil].
    Yamashita K; Mitani K; Morishita Y; Inoue K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):767-73. PubMed ID: 2496666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nucleosides, 5-phosphoribosyl-1-pyrophosphate, and ribose 1-phosphate in the biosynthesis of phosphosphingolipids in Bacteroides melaninogenicus.
    Lev M; Milford AF
    Arch Biochem Biophys; 1978 Jan; 185(1):82-7. PubMed ID: 23730
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
    Ramaekers F; van Niekerk C; Poels L; Schaafsma E; Huijsmans A; Robben H; Schaart G; Vooijs P
    Am J Pathol; 1990 Mar; 136(3):641-55. PubMed ID: 1690512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.